ED
ABEV icon

Exane Derivatives’s Ambev ABEV Stock Holding History

Exane Derivatives’s Portfolio ABEV Stock Details ABEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-2,500
Closed -$15.2K – 532
2015
Q2 		$15.2K Hold
2,500
– – ﹤0.01% 349
2015
Q1 		$14.4K Hold
2,500
– – ﹤0.01% 366
2014
Q4 		$15.5K Buy
+2,500
New +$15.8K ﹤0.01% 399

Other funds holding ABEV

VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.8B AUM 25.03% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
GTP
Global Thematic Partners New York $120M AUM 25.18% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Exane Derivatives's ABEV Position: Q3 2015 in Review

Exane Derivatives sold out of Ambev (ABEV) in Q3 2015, closing a stake of 2,500 shares — an estimated $15.2K sold.

Exane Derivatives first reported a position in ABEV in Q4 2014 and held it in 3 quarters. The position peaked at $15.5K in Q4 2014. 301 funds tracked by Wall St. Rank hold ABEV as of Q3 2015.

  • Exane Derivatives reported no remaining Ambev position as of Q3 2015 after selling out during the quarter.
  • Exane Derivatives sold 2,500 Ambev shares in Q3 2015, an estimated $15.2K.
  • Exane Derivatives first reported a position in Ambev in Q4 2014 and held it in 3 quarters.
  • Exane Derivatives's Ambev position peaked at $15.5K in Q4 2014.
  • 301 funds tracked by Wall St. Rank held Ambev as of Q3 2015.

Based on Exane Derivatives's 13F filing for Q3 2015, filed 13 Nov 2015.